Sensei Biotherapeutics, Inc.
SNSE
$12.63
-$0.37-2.85%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -535.42% | 30.08% | 19.00% | 9.60% | 9.05% |
| Total Depreciation and Amortization | -86.83% | -89.49% | -66.97% | -44.39% | -22.58% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3,809.00% | -55.20% | -35.60% | -32.05% | -28.08% |
| Change in Net Operating Assets | 15,832.91% | -225.56% | -42.93% | -95.81% | 103.08% |
| Cash from Operations | 0.23% | 17.09% | 10.62% | -0.14% | 13.46% |
| Capital Expenditure | 79.82% | 89.04% | 89.04% | 89.04% | -65.15% |
| Sale of Property, Plant, and Equipment | 425.00% | -- | -- | -- | -74.52% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -206.59% | -13.50% | -57.92% | -13.33% | -42.72% |
| Cash from Investing | -179.02% | -11.89% | -57.05% | -12.10% | -43.01% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 22.11% | 2.59% | -10.50% | -19.08% | -6.33% |
| Issuance of Common Stock | 2,958.82% | -79.41% | -52.63% | -52.63% | -29.17% |
| Repurchase of Common Stock | 66.67% | 60.00% | 98.47% | 99.88% | 99.97% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 23,508.46% | 18.04% | 28.91% | 76.74% | 92.88% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 13,301.85% | 56.05% | -210.03% | -60.00% | -137.90% |